У нас вы можете посмотреть бесплатно EP 222: From genetic risk to gene editing in heart failure with Travis Hinson of JAX and UConn или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
This week on The Genetics Podcast, Patrick is joined by Dr. Travis Hinson, Professor and physician at the University of Connecticut and investigator at the Jackson Laboratory. They discuss how genetics is reshaping the understanding of heart failure, why sarcomere biology has become a central target for new gene-based therapies, and how advances in genome editing and preventive genetics could redefine cardiovascular care. Show Notes: 0:00 Intro to The Genetics Podcast 01:00 Welcome to Travis 01:46 Overview of gene editing for inherited cardiovascular disease 05:14 Delivery methods and viral capsid engineering to target heart tissue 07:50 Role of the titin gene in dilated cardiomyopathy and treatment opportunities 11:03 Genetic variants in titin and differences in phenotype 14:30 Promising therapeutic approaches for targeting titin 17:11 Possibility of using a mini titin gene for replacement 18:25 Sarcomere proteins and their role in cardiomyopathy 21:37 Limits of current understanding in heart failure, including cardiac regeneration and congenital heart disease 26:10 Predicting drug-induced cardiotoxicity using stem cell models, animal studies, and digital twins 31:35 How Travis balances clinical genetics at the University of Connecticut with translational research at the Jackson Laboratory (JAX) 33:43 Where genetic testing is used in cardiology today and what’s limiting broader access 37:08 Understanding polygenic risk and unexplained heritability in cardiovascular disease 39:00 Managing inherited cardiomyopathy risk in families after a pathogenic variant is identified 42:33 Genetic testing as a prevention strategy and the public health case for earlier intervention 45:06 Balancing early genetic screening with penetrance, uncertainty, and patient anxiety 47:58 Closing remarks Find out more: Review on cardiovascular gene editing approaches (https://link.springer.com/article/10....) Please consider rating and reviewing us on your chosen podcast listening platform! https://drive.google.com/file/d/1Bp2_...